文献速递泌尿男性生殖肿瘤

诊断年龄与前列腺癌治疗及预后:一项基于人群的队列研究

Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study.
PubMed 文献 · Ann Oncol · 2018-01-01

结果显示高龄患者合并症更多、PSA检测发现更少、分期更晚且根治性治疗更少;校正治疗分层后,高龄在延迟治疗、雄激素剥夺治疗或根治性前列腺切除术中与更差预后相关,但放疗中无此关联。结论不支持年龄本身对前列腺癌死亡风险有强内在影响,而提示高龄患者诊断评估和根治性治疗不足。

要点

  • 高龄前列腺癌患者合并症更多、PSA检测发现更少、分期更晚且根治性治疗更少。
  • 延迟治疗、雄激素剥夺治疗或根治性前列腺切除术后,高龄与更差预后相关。
  • 放疗亚组中未观察到高龄与更差预后的独立关联。

核心结论

  • 研究结果不支持年龄对前列腺癌死亡风险有强内在效应,但提示当前临床实践中高龄患者诊断评估和根治性治疗不足。

研究设计与样本

  • 使用Cox回归计算风险比(HR)和95%置信区间(CI)。

主要发现

  • 延迟治疗组中,诊断年龄85岁及以上 versus 60-64岁的HR为7.19(95% CI: 5.61-9.20)。
  • 雄激素剥夺治疗组中,诊断年龄85岁及以上 versus 60-64岁的HR为1.72(95% CI: 1.61-1.84)。
  • 根治性前列腺切除术组中,诊断年龄75岁及以上 versus 60-64岁的HR为2.20(95% CI: 1.01-4.77)。
  • 放疗组中,诊断年龄75岁及以上 versus 60-64岁的HR为1.08(95% CI: 0.76-1.53)。

临床怎么用

  • 对高龄前列腺癌患者应充分评估合并症并完善诊断分期,避免治疗不足。
  • 在高龄患者中考虑根治性治疗时需个体化权衡获益与风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Old age at prostate cancer diagnosis has been associated with poor prognosis in several studies. We aimed to investigate the association between age at diagnosis and prognosis, and if it is independent of tumor characteristics, primary treatment, year of diagnosis, mode of detection and comorbidity. PATIENTS AND METHODS: We conducted a nation-wide cohort study including 121 392 Swedish men aged 55-95 years in Prostate Cancer data Base Sweden 3.0 diagnosed with prostate cancer in 1998-2012 and followed for prostate cancer death through 2014. Data were available on age, stage, grade, prostate-specific antigen (PSA)-level, mode of detection, comorbidity, educational level and primary treatment. We used Cox regression to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: With increasing age at diagnosis, men had more comorbidity, fewer PSA-detected cancers, more advanced cancers and were less often treated with curative intent. Among men with high-risk or regionally metastatic disease, the proportion of men with unknown M stage was higher among old men versus young men. During a follow-up of 751 000 person-years, 23 649 men died of prostate cancer. In multivariable Cox-regression analyses stratified by treatment, old age at diagnosis was associated with poorer prognosis among men treated with deferred treatment (HRage 85+ versus 60-64: 7.19; 95% CI: 5.61-9.20), androgen deprivation therapy (HRage 85+ versus 60-64: 1.72; 95% CI: 1.61-1.84) or radical prostatectomy (HRage 75+ versus 60-64: 2.20; 95% CI: 1.01-4.77), but not radiotherapy (HRage 75+ versus 60-64: 1.08; 95% CI: 0.76-1.53). CONCLUSION: Our findings argue against a strong inherent effect of age on risk of prostate cancer death, but indicate that in current clinical practice, old men with prostate cancer receive insufficient diagnostic workup and subsequent curative treatment.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Pettersson A, Robinson D, Garmo H, et al. Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol. 2018. PMID: 29161337. doi:10.1093/annonc/mdx742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。